Abstract: A projection video display that projects video image suppresses deterioration of its quality which is attributed to a change in an optical path of the video image. A video signal generator performs control such that a second subframe in an N-th frame in a left-eye image is displayed on DMDs and then a second subframe in an N-th frame in a right-eye image is displayed on the DMDs. Furthermore, the video signal generator performs control such that a displayed location is not changed on a screen and the same types of subframes are displayed at the time when frames are switched.

Abstract: The present invention provides an erythropoietin expression-enhancing agent that can cancel the suppression of erythropoietin production or promote erythropoietin production, and a therapeutic or preventive drug for anemia, a liver function-improving agent, an ischemic injury-improving agent, a renal protective agent, and an insulin secretagogue comprising the erythropoietin expression-enhancing agent. The erythropoietin expression-enhancing agent of the present invention comprises one or more compounds selected from the group consisting of compounds represented by the following general formulas (I), (II), and (III) and pharmaceutically acceptable salts thereof when R3 is OH.

Abstract: An object of the present invention is to provide a biomarker capable of determining the onset risk or the stage of diabetic nephropathy (early-stage diabetic nephropathy in particular). Diabetic nephropathy is determined by measuring or quantitatively determining a concentration of phenyl sulfate or a salt thereof (a phenyl sulfate) contained in a biological sample, preferably plasma or urine, collected from a test subject to detect a phenyl sulfate. The present invention exhibits excellent effects particularly for stage determination for stage 1 (pre-nephropathy stage) to stage 3 (overt nephropathy stage), or for determination of onset risk of diabetic nephropathy (diabetic nephropathy at pre-nephropathy stage).

Abstract: The projection image display apparatus includes a display element that emits image light generated by modulating light from a light source based, a pixel-shifter that shifts a pixel of a projected image by changing an optical path of the image light, a resampling circuit, a motion-interpolation image processing circuit, and a pixel-shift controller. The resampling circuit generates a plurality of sub-frame image signals having a resolution of the display element, by resampling an image signal having a resolution of the projected image. The motion-interpolation image processing circuit provides a motion-interpolation image process to the sub-frame image signals. The pixel-shift controller receives the sub-frame image signals having undergone the motion-interpolation image process.

Abstract: The present invention provides an erythropoietin expression-enhancing agent that can cancel the suppression of erythropoietin production or promote erythropoietin production, and a therapeutic or preventive drug for anemia, a liver function-improving agent, an ischemic injury-improving agent, a renal protective agent, and an insulin secretagogue comprising the erythropoietin expression-enhancing agent. The erythropoietin expression-enhancing agent of the present invention comprises one or more compounds selected from the group consisting of compounds represented by the following general formulas (I), (II), and (III) and pharmaceutically acceptable salts thereof when R3 is OH.

Abstract: Image display system 10 comprises: a plurality of display devices 111; an image processing unit for receiving input of a plurality of input video signals and generating an output video signal for each display device in accordance with a layout for the display devices from the input video signals; a pattern signal generation unit for generating pattern signals indicating a plurality of different test pattern images; a selector for receiving input of the output video signals and the pattern signals and selecting and outputting either the output video signals or the pattern signals; imaging device 120 for capturing an image of the test pattern images displayed on the respective display devices; and a control device 140 for analyzing the captured image captured by the imaging device and generating control information for controlling the image processing unit, based on analysis results.

Abstract: The optical path changing device of the present disclosure includes an optical member having a parallel plate face for changing an optical path, and first, second, and third actuators. The first, the second, and the third actuators are connected with the optical member at first, second, and third vertices of a triangle imaginarily drawn on a plane parallel to the parallel plate face of the optical member. The first, the second, and the third actuators drive the optical member forward and backward in a normal direction of the parallel plate face at the first, the second, and the third vertices serving as points of load. The optical member has a center of gravity within the triangle when seen from the normal direction.

Abstract: A projection-type image display apparatus includes a light source unit, an image generating unit that generates image light according to an input video signal, a light-guide optical system that guides the light from the light source unit to the image generating unit, a projection optical system that projects the image light generated by the image generating unit, and a controller. The controller has a display mode in which the image light is projected and an illumination mode in which the light from the light source unit is emitted as illumination light. The controller controls the optical system to focus illumination light from the projection optical system on a projection surface, in the display mode, and to focus illumination light from the projection optical system at a position different from the projection screen, in the illumination mode.

Abstract: A negative electrode for a secondary battery according to the present invention has a collector and a negative electrode active material layer formed on a surface of the collector and containing negative electrode active material particles. In the negative electrode active material layer, an insulating material is arranged between the negative electrode active material particles so as not to develop conductivity by a percolation path throughout the negative electrode active material layer. It is possible in this configuration to effectively prevent the occurrence of a short-circuit current due to an internal short circuit and the generation of heat due to such short-circuit current flow in the secondary battery while securing the battery performance of the secondary battery.

Abstract: A projection video display that projects video image suppresses deterioration of its quality which is attributed to a change in an optical path of the video image. A video signal generator performs control such that a second subframe in an N-th frame in a left-eye image is displayed on DMDs and then a second subframe in an N-th frame in a right-eye image is displayed on the DMDs. Furthermore, the video signal generator performs control such that a displayed location is not changed on a screen and the same types of subframes are displayed at the time when frames are switched.

Abstract: The projection image display apparatus includes a display element that emits image light generated by modulating light from a light source based, a pixel-shifter that shifts a pixel of a projected image by changing an optical path of the image light, a resampling circuit, a motion-interpolation image processing circuit, and a pixel-shift controller. The resampling circuit generates a plurality of sub-frame image signals having a resolution of the display element, by resampling an image signal having a resolution of the projected image. The motion-interpolation image processing circuit provides a motion-interpolation image process to the sub-frame image signals. The pixel-shift controller receives the sub-frame image signals having undergone the motion-interpolation image process.

Abstract: The optical path changing device of the present disclosure includes an optical member having a parallel plate face for changing an optical path, and first, second, and third actuators. The first, the second, and the third actuators are connected with the optical member at first, second, and third vertices of a triangle imaginarily drawn on a plane parallel to the parallel plate face of the optical member. The first, the second, and the third actuators drive the optical member forward and backward in a normal direction of the parallel plate face at the first, the second, and the third vertices serving as points of load. The optical member has a center of gravity within the triangle when seen from the normal direction.

Abstract: A therapeutic and/or prophylactic agent for renal anemia comprising ALAs and an erythropoietin production promoter comprising ALAs.

Abstract: A projection display apparatus includes an image generation unit that generates an image light, an optical system that projects the image light onto a projection plane, an optical path changing unit that changes a display position of the image light on the projection plane, and a controller. The controller generates signals for plural types of sub-frames by dividing spatially a signal for each frame of the video input signal. The controller controls the optical path changing unit to keep the display position of the image light on the projection plane before and after transition of the frame of the video signal, and controls the image generation unit to make a type of a beginning sub-frame in a frame output just after the transition equal to a type of a last sub-frame in a frame output just before the transition.

Abstract: An object of the present invention is to provide an agent for preventing or ameliorating renal dysfunction, excellent in the inhibitory action on the advance of renal dysfunction, the suppressive action on renal fibrosis, the suppressive action on the development of renal failure, and the suppressive action on nephritis.

Abstract: An automobile cell is provided with an electric power generating element composed of a positive electrode having a positive electrode active substance layer, a negative electrode having a negative electrode active substance layer and a separator interposed between the electrodes, a cell outer sheath made of a laminate film compositely composed of polymer and metal, a positive electrode terminal lead electrically conductive with the positive electrode and extending to an outside of the cell outer sheath, and a negative electrode terminal lead electrically conductive with the negative electrode and extending to the outside of the cell outer sheath.

Abstract: A battery module 11 is structured to include a flat-type battery 40 in which current can be taken out from both faces of an electric generation element 20 in a layered direction, flat-plate-type electrode tabs 50 and 60 having a face contact with a current-taking-out plane of the flat-type battery to take out current, and a packaging case 100 covering the flat-type battery and the electrode tab. The inner face of the packaging case and the electrode tab have therebetween an elastic member 120.

Abstract: A projection-type image display apparatus includes a light source unit, an image generating unit that generates image light according to an input video signal, a light-guide optical system that guides the light from the light source unit to the image generating unit, a projection optical system that projects the image light generated by the image generating unit, and a controller. The controller has a display mode in which the image light is projected and an illumination mode in which the light from the light source unit is emitted as illumination light. The controller controls the optical system to focus illumination light from the projection optical system on a projection surface, in the display mode, and to focus illumination light from the projection optical system at a position different from the projection screen, in the illumination mode.

Abstract: A battery control device is provided that uses a discharge to adjust the capacitance of cells that form a bipolar battery and calculates the voltage increase value of the remaining cells that do not discharge to adjust capacitance if one or more cells, among all of the cells that form the bipolar battery, are discharged to adjust capacitance in a battery control device that controls voltage dispersion or volume dispersion between cells that form the bipolar battery; and setting the general discharge value when there is a discharge to adjust capacitance on the basis of the result of the voltage increase value calculation.

Abstract: The present invention provides an erythropoietin expression-enhancing agent that can cancel the suppression of erythropoietin production or promote erythropoietin production, and a therapeutic or preventive drug for anemia, a liver function-improving agent, an ischemic injury-improving agent, a renal protective agent, and an insulin secretagogue comprising the erythropoietin expression-enhancing agent. The erythropoietin expression-enhancing agent of the present invention comprises one or more compounds selected from the group consisting of compounds represented by the following general formulas (I), (II), and (III) and pharmaceutically acceptable salts thereof when R3 is OH.